title: Key learnings from the Endocrine Disruptor Screening Program (EDSP) Tier 1 rodent uterotrophic and Hershberger assays.
abstract: In 2009, companies began screening compounds using the US Environmental Protection Agency's Endocrine Disruptor Screening Program (EDSP). EDSP has two tiers: Tier 1 includes 11 assays to identify compounds with potential endocrine activity. This article describes two laboratories' experiences conducting Tier 1 uterotrophic and Hershberger assays. The uterotrophic assay detects estrogen receptor agonists through increases in uterine weight. The advantages of the uterotrophic rat models (immature vs. adult ovariectomized) and exposure routes are discussed. Across 29 studies, relative differences in uterine weights in the vehicle control group and 17α-ethynylestradiol-positive control group were reasonably reproducible. The Hershberger assay detects androgen receptor (AR) agonists, antagonists, and 5α-reductase inhibitors through changes in accessory sex tissue (AST) weights. Across 23 studies, AST weights were relatively reproducible for the vehicle groups (baseline), testosterone propionate (TP) groups (androgenic response), and flutamide + TP groups (antiandrogenic response). In one laboratory, one and four compounds were positive in the androgenic and antiandrogenic portions of the assay, respectively. Each compound was also positive for AR binding. In the other laboratory, three compounds showed potential antiandrogenic activity, but each compound was negative for AR binding and did not fit the profile for 5α-reductase inhibition. These compounds induced hepatic enzymes that enhanced testosterone metabolism/clearance, resulting in lower testosterone and decreased capacity to maintain AST weights. The Hershberger androgenic and antiandrogenic performance criteria were generally attainable. Overall, the uterotrophic and Hershberger assays were easily adopted and function as described for EDSP screening, although the mode of action for positive results may not be easily determined.
authors: Toxicology & Environmental Research and Consulting, The Dow Chemical Company, Midland, Michigan.
authors: M Sue
authors: MS
authors: Marty
authors: John C
authors: JC
authors: O'Connor
mesh_terms: D000822:Animal Husbandry; D000818:Animals; D001681:Biological Assay / Q000379:methods*; D052244:Endocrine Disruptors / Q000032:analysis* / Q000633:toxicity*; D023381:Endpoint Determination; D005260:Female; D009929:Organ Size; D051381:Rats; D013223:Statistics as Topic; D014599:Uterus / Q000033:anatomy & histology* / Q000187:drug effects*
chemical_list: D052244:Endocrine Disruptors
keywords: 5α-reductase inhibitor; EDSP; Hershberger; androgen; antiandrogen; endocrine disruptor; endocrine disruptor screening program; endocrine screening; estrogen; uterotrophic